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INTRODUCTION
Bacterial vaginosis (BV) is the most common infec-
tion in vagina. BV is also the most common cause
of the abundant vaginal secret. BV could cause ab-
normal vaginal secret, itchy sensation and foul
smell.1,2
Clinical criteria used for diagnosing bacterial
vaginosis is the Amsel criteria, ie vaginal pH > 4.5,
the existence of a homogeneous vaginal discharge,
the occurrence of fishy odor after application of
KOH (potassium hydroxide) to the vaginal secret,
and the presence of clue cells on microscopic ex-
amination. The diagnosis of BV is made when at
least three out those four criteria are fulfilled.2
Bacterial vaginosis usually occurs due to an im-
balance of the normal vaginal microorganisms
population. Lactobacilli bacteria is found to be re-
duced while other microorganism, Gardnerella
vaginalis, increase. The main therapy for Bacterial
vaginosis is metronidazole 500 mg, given 2 times
a day for 7 days . However, treatment with antibi-
otics can be followed with the incidence of recur-
rent Bacterial vaginosis and resistance to the anti-
biotic. Therefore, we need to try finding other al-
ternatives as therapy. One of the proposed
alternative is using probiotics to restore the nor-
mal population of Lactobacilli in vagina.3-5 The use
of probiotics can be also used as a preventive ther-
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Objective : This study aims to assess the effect of the addition of pro-
biotic supplement to the standard therapy on the recovery of Bacte-
rial vaginosis infection.
Methods: The research was conducted by taking samples from Ob-
stetrics and Gynecology Department in several teaching hospitals of
Faculty of Medicine, Hasanuddin University. This study was an ex-
perimental study. Consecutive sampling was conducted on 50 sam-
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the chi-square test.
Results: There is no significant difference in the recovery of bacte-
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Abstrak
Tujuan: Penelitian ini bertujuan untuk menilai efek suplemen probio-
tik bersama terapi standar terhadap penyembuhan Bacterial vagi-
nosis.
Metode: Penelitian ini dilakukan dengan mengambil sampel peneli-
tian di beberapa rumah sakit pendidikan Bagian Obstetri dan Gine-
kologi Fakultas Kedokteran Universitas Hasanuddin. Metode peneli-
tian yang digunakan dalam penelitian ini adalah uji klinis. Dilakukan
consecutive sampling terhadap 50 sampel yang terbagi atas dua
kelompok, yaitu kelompok 1 yang mendapat terapi Metronidazol oral
2 x sehari selama 7 hari, sedang kelompok 2 diberikan terapi Metroni-
dazol 2 x sehari ditambahkan dengan Probiotik oral 1 x sehari selama
7 hari. Data dianalisis dengan menggunakan uji Chi-Square.
Hasil: Hasil penelitian ini menunjukkan tidak ada perbedaan yang sig-
nifikan dari efek penambahan probiotik pada terapi standar terhadap
Bacterial vaginosis (p>0,05).
Kesimpulan: Penambahan probiotik pada terapi standar tidak
menunjukkan efek terhadap penyembuhan Bacterial vaginosis.
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apy against bacterial vaginosis, where probiotics
can restore normal vaginal flora.5 Several studies
have also reported that probiotics can be an alter-
native as a substitute for antibiotics.6
Many studies showed that the H2O2 produced by
vaginal lactobacilli can prevent Bacterial vaginosis,
although some other studies do not support this
hypothesis. The use of probiotics for the preven-
tion and treatment of infection has a strong foun-
dation and relatively safe, especially for Bacterial
Vaginosis . Side effects from the use of probiotics
is rarely found, and even if found, it tends to be a
mild gastrointestinal complaints.7,8
In the study conducted by Falagas et al, it was re-
ported that the use of probiotics is an effective ele-
ment in the treatment and prevention of bacterial
vaginosis . Study demonstrated a significant relation-
ship between low concentrations of vaginal lactoba-
cilli and the incidence of Bacterial vaginosis. The in-
vitro study showed that certain strains of Lactobacilli
can inhibit the development of Gardnella vaginalis in
vaginal epithelium and the production of H2O2 and
lactic acid can inhibit the growth of bacteria that can
cause bacterial vaginosis.8
Based on this background, we found that it is
necessary to conduct a clinical trial on the effects
of probiotic supplementation with standard ther-
apy in the recovery of bacterial vaginosis.
METHOD
The research was conducted by taking samples
from Obstetrics and Gynecology Department in
several teaching hospitals of Faculty of Medicine,
Hasanuddin University. This study was an experi-
mental study. Consecutive sampling was conducted
on 50 subjects who fulfilled the inclusion criteria,
which were then divided into two groups. Group 1
received Metronidazol therapy 2 times a day for 7
days, while group 2 received Metronidazol therapy
2 times a day supplemented with oral Probiotic of
once a day for 7 days. The data were analysed by
using the chi-square test.
RESULT
This study was performed on 50 women with com-
plaints of vaginal discharge that met the inclusion
criteria. The subjects were divided into 2 groups.
Group 1 consisted of 25 patients who received
standard therapy and group 2 consisted of 25 peo-
ple who received standard therapy and a probiotic
supplement. The subject assignment into these two
groups were performed randomly.
Characteristics of the samples include maternal
age, parity, maternal education, and maternal em-
ployment. Basic characteristics of the study sample
was obtained from the value of a statistical descrip-
tion of which is illustrated by the number of each
variable, as can be seen in the Table 1.
Table 1. The Characteristic of the Subject
Variable
Metronidazole
only group
Metronidazole
+ probiotic group
(n=25) % (n=25) %
Age
20 - 30
31 - 40
 5
20
20
80
 5
20
20
80
Parity
0
1
2
3
≥ 4
 4
 5
 5
 2
 9
16
20
20
 8
36
 2
 1
 7
 4
11
 8
 4
28
16
44
Education
Junior high school
Senior high school
College graduate
 5
15
 5
20
60
20
 4
18
 3
16
72
12
Occupation
Housewife
Enterpreneur
Public officer
17
 6
 2
68
24
 8
15
 6
 4
60
24
16
Table 1 shows that most subjects were in the
age group of 31-40 years (80%) in both group 1
and group 2. Most subjects had given birth ≥ 4
times, as many as 9 subjects (36%) in group I and
11 subjects (44%) in group II. The majority of sub-
jects were graduated from senior high school. The
most common occupation was housewife.
Before therapy, the homogenous vaginal secret
was found in all subjects in both groups. After ther-
apy, there was only 6 people (24%) in group 1 who
were still positive and 4 people (16%) in group 2
who were stil positive. Based on the statistical test,
we found that there was no significant differences
regarding the presence of vaginal discharge after
treatment in both groups (p > 0.05).
From the examination of KOH test, there were
18 people (72%) tested positive in group 1 and 19
people (76%) in Group 2. Based on statistical tests
of the two groups obtained p values > 0.05, mean-
ing that there was no significant difference in the
examination of KOH test prior to therapy. After
therapy, 11 subjects (61.1 %) were tested negative
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in group 1, while 13 subjects ( 68.5 % ) were tested
negative in group 2. There was no significant dif-
ference in the examination of KOH test after treat-
ment in both groups.
From the examination of vaginal pH, there were
17 subjects (68%) tested positive in group 1 and
20 subjects (80%) tested positive in group 2. Then
after therapy 12 subjects (70.6%) were tested
negative in group 1 and 11 subjects (55%) were
negative. Based on statistical tests found no signifi-
cant differences in the pH of the vaginal examina-
tion after therapy in both groups with p > 0.05
From the examination of clue cells, there were
19 subjects (76%) tested positive in group 1 and
16 subjects (64%) in group 2. After therapy there
were 10 people (52.6%) tested negative in group
1, and 10 subjects (62.5%) in group 2 . Then the
obtained value of the test statistic p > 0.05 means
that there is no significant difference in the exami-
nation of vaginal clue cells after treatment in both
groups.
Table 3. Bacterial Vaginosis after Therapy in both Groups
Groups
Result
Total pCured Not cured
n % n %
Metronidazole 19 76 6 24 25 100 0.747
Metronidazole+
probiotic
18 72 7 28 25 100
Note: p: Pearson Chi-Square test
Table 3 shows that 19 subjects (76%) were
cured in group 1 and 18 people (72%) were cured
in group 2. From statistical tests using Pearson Chi-
Square test, it was found that there was no signifi-
cant difference between the two groups (p> 0.05).
DISCUSSION
Bacterial vaginosis (BV) is the most common infec-
tion in vagina. BV is also the most common cause
of the abundant vaginal secret.1,2 We performed a
clinical trial comparing the use of metronidazole
only and metronidazole supplemented by probiotic
in the management of bacterial vaginosis.
In this study, most subjects were in the age
group of 31-40 years (80%) in both groups. Several
previous studies reported that Bacterial vaginosis
is more common in younger women.9 Meanwhile,
another study showed that the risk of bacterial
vaginosis increases with increasing age.10 Our
study’s finding was similar to the later study. This
may be associated with the lower estrogen levels
at this age. Decreased levels of estrogen causes an
increase in vaginal pH, so this condition is not op-
timal for the development of Lactobacillus sp, a
normal vaginal flora , but very conducive to the
growth of microorganisms that cause bacterial
vaginosis.10
Most subjects had given birth ≥ 4 times in both
treatment groups . Research conducted by P. Bhalla
and A. Kaushika in 1994 found a significant rela-
Table 2. The Examination of Amsel Criteria before and after Therapy in both Group
Amsel
criteria
Before therapy After therapy
Metronidazole+
Metronidazole Probiotic p
Metronidazole +
Metronidazole Probiotic p
n % n % n % n %
Vaginal secret
Positive
Negative
25
 0
100 
 0
25
 0
100 
 0 *
 6
19
24   
76   
 4
21
16   
84   0.48 
Snif (KOH) test
Positive
Negative
18
 7
72
28
19
 6
76
24 0.747
 7
11
38.90
61.10
 6
13
31.50
68.50 0.642
Vaginal pH
Positive
Negative
17
 8
68
32
20
 5
80
20 0.333
 5
12
29.40
70.60
 9
11
45   
55   0.33 
Clue cells
Positive
Negative
19
 6
76
24
16
 9
64
36 0.424
 9
10
47.40
52.69
 6
10
37.50
62.50 0.557
Note:* : No statistics are computed because variable is a constant
p: Pearson Chi-Square test
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tionship between the incidence of bacterial vagi-
nosis with higher parity.11 Meanwhile, in 2004 a
study by multivariate analysis found that there was
no relationship between the incidence of bacterial
vaginosis and parity.12
 The majority of subjects were graduated from
senior high school. The most common occupation
was housewife. Both of these variables are related
to the socio-economic level. Research conducted by
Tamonud Modak et al in 2011 found that all sub-
jects with bacterial vaginosis were from a low so-
cioeconomic level.13 It could be explained that the
subjects with lower socioeconomic had a low
awareness in personal and environmental hygiene,
thus more susceptible to infection.
Bacterial vaginosis usually occurs due to an im-
balance of the normal vaginal microorganisms
population. Lactobacilli bacteria is found to be re-
duced while other microorganism, Gardnerella
vaginalis, increase. The main therapy for Bacterial
vaginosis is metronidazole 500 mg, given 2 times
a day for 7 days. However, treatment with antibi-
otics can be followed with the incidence of recur-
rent Bacterial vaginosis and resistance to the anti-
biotic. Therefore, we need to try finding other al-
ternatives as therapy. One of the proposed
alternative is using probiotics to restore the nor-
mal population of Lactobacilli in vagina.3-5
The goal of probiotic therapy in addition to
standard therapy is to restore the normal balance
of vaginal microorganisms populations, which con-
tains probiotics lactobacilli required by normal
vaginal ecosystem. Research conducted by Gabriela
Lilies et al showed that probiotic supplementation
therapy may increase the effectiveness in the man-
agement of Bacterial vaginosis.14
The result of homogeneity examination towards
both group based on the amsel criteria before ther-
apy showed that both groups were homogenous
population with p>0.05.
The influence of probiotic supplementation in
the standard therapy were reassessed after 7 day
of therapy. The reassessment included vaginal se-
cret examination, Sniff test, vaginal pH examination
and the examination for the presence of clue cells.
The statistical analysis towards all criteria after
therapy showed that there was no significant dif-
ference in both groups. There was no difference
either in the overall recovery of subjects in both
groups.
This result is consistent with the research con-
ducted by Katarina Eriksson et al. which found that
there was no significant difference in the recovery
rates between treatment with only antibiotic and
antibiotic supplemented with probiotic.15 But in re-
search conducted by Lilior et al, it was showed that
treatment with probiotic supplements can increase
the effectiveness of management on bacterial vagi-
nosis.14 Similarly, the study by Valentine Marcone
also found that probiotics can significantly increase
the effectiveness of antibiotic therapy.16
CONCLUSION
Addition of probiotic supplements do not increase
the effectiveness of antibiotics in the treatment of
bacterial vaginosis.
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